U.S. equities finished lower on Tuesday, August 11, 2026, extending a modest two-session pullback from recent record levels. Concerns that a resolution to the U.S.-Iran standoff may take longer than hoped helped keep oil prices elevated, while investors positioned cautiously ahead of…
U.S. equities finished modestly lower on Monday as a sharp move higher in crude oil renewed inflation concerns ahead of this week’s key U.S. inflation data. The session reflected measured risk reduction rather than broad capitulation: volatility rose, technology lagged, and energy…
Week ending Friday, August 7, 2026 — U.S. equities finished the week decisively higher, led by technology and smaller-capitalization shares. The market’s message was nuanced: economic activity indicators remained firm, but July’s unexpected payroll decline reinforced the view that the labor market…
All major U.S. stock indexes finished lower Thursday as investors weighed fresh geopolitical risks in the Middle East, firmer Treasury yields and a murky Federal Reserve outlook against strong but increasingly priced-in enthusiasm around artificial intelligence and corporate earnings. The S&P 500…
Amwell (NYSE: AMWL) is trying to do something rare in healthcare technology: become more interesting by becoming less dramatic. After years of telehealth hype, backlash, and normalization, the company’s latest setup suggests a business leaning into discipline, enterprise relevance, and just enough…
Amwell’s setup going into Q2 2026 looks like the kind of telehealth story Wall Street loves to rediscover right after it has ignored it for too long. The company’s August 4 aftermarket earnings report and 5 p.m. ET webcast arrive with a…
Amwell’s (AMWL) leadership page reads like a small thesis on where digital care is trying to go: a mix of clinicians, operators, and technologists built to make virtual healthcare feel less like a workaround and more like a workflow. That matters because…
Amwell, Inc. (NYSE: AMWL, $13,02, +165.07% YTD)) is quietly scripting one of Wall Street’s more intriguing digital‑health turnarounds—an AI‑infused, platform‑first story backed by a management bench that looks more like a health‑tech all‑star team than a typical telehealth cast.
Digital Care, Rewritten…
Beef is getting pricier just as biotech is getting hotter, and for investors willing to look past the grocery aisle to the lab bench, that may be the more interesting inflation story.
From Ribeye Shock to Risk-On: The Macro Backdrop
Consumers may…
Butterfly Network’s (BFLY) Midjourney cameo now sits inside a bigger, more nuanced script: AI‑driven imaging that can delight investors, unnerve ethicists, and occasionally confuse radiologists—all while telehealth platforms like Amwell (AMWL) quietly wire the whole thing into everyday care. The result is…
